Mondaq All Regions: Food, Drugs, Healthcare, Life Sciences
McCarthy Tétrault LLP
As cannabis legalization moves north of the border, cannabis companies in Canada will inevitably face similar legal issues as they have in the United States, where the decriminalization of cannabis in several jurisdictions ...
Houser Henry & Syron LLP
The legalization of recreational cannabis on October 17, 2018 creates new legal issues that landlords must now address.
Houser Henry & Syron LLP
On October 19, 2018, the purchase of recreational cannabis became legal under the Cannabis Act. In the past three months, 16% of Canadians reported using cannabis.[1] Use is expected to increase.
Thompson Dorfman Sweatman LLP
From an entrepreneur's perspective…how to prepare and what to expect, exporting experience – opportunities and challenges.
McCarthy Tétrault LLP
The World Health Organization (the "WHO"), by meeting of the Expert Committee on Drug Dependence ("ECDD"), has updated its position on medicinal cannabis and cannabinoids ...
Bennett Jones LLP
With their access to local and global investors and finance opportunities for companies at all stages, Canada's world leading cannabis capital markets offer a wealth of opportunity.
Singh & Associates
The approval and launch of new medicines/biological products for marketing often means the availability of new treatment for patients and advancement in health care.
Singh & Associates
We are in the era, where the world is facing multiple health challenges ranging from outbreaks of vaccinepreventable diseases, increasing number of drug-resistant pathogens, growing rates of non-communicable diseases, increasing rate of environmental pollution and climate change and multiple humanitarian crises.
Khurana and Khurana
By now, she had begun using cannabis in the form of oil as an alternative to smoking.
Singh & Associates
The European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) recommended six medicines for approval, including two biosimilar and two generic medicines at its January 2019 meeting.
Singh & Associates
The Delhi High Court, on January 01, 2019, set aside the Central Government's ban on Wockhardt's anti-inflammatory medicine ‘Ace Proxyvon', a Fixed Dose combination of Aceclofenac 100 mg, Paracetamol 325 mg ...
Dentons
Spoločnosti podnikajúce v oblasti life sciences pravidelne čelia novým výzvam súvisiacimi s aktuálnymi zmenami legislatívy.
BCL Solicitors LLP
Increasingly, businesses in the UK are looking at entering into, or investing in, the legal cannabis industry, domestically or overseas.
Reed Smith
Our recent post about the First Amendment decision in American Beverage Ass'n v. City & County of San Francisco, ___ F.3d ___, 2019 WL 387114 (9th Cir. Jan. 31
BakerHostetler
Senate Democrats recently introduced the Stop Price Gouging Act (S. 378), which seeks to place an excise tax on pharmaceutical companies in proportion to price spikes on prescription drugs.
Wilson Elser Moskowitz Edelman & Dicker LLP
This is the first in a three-part series of articles on cannabis laws and court opinions. Today's article reviews different rulings on federal pre-emption of state marijuana laws.
Foley & Lardner
The U.S. Department of Health and Human Services (HHS) recently proposed two new rules designed to increase patient and provider access to health records
Seyfarth Shaw LLP
Welcome back to The Week in Weed, your Friday look at what's happening in the world of legalized marijuana.
McDermott Will & Emery
New digital health regulations arose at the federal and state level in 2018, bolstering the existing legal framework to further support and encourage digital health adoption in the context of care coordination and the move to value-based payment.
Mintz
Federal regulators are flexing their regulatory muscle to accelerate a long-desired but often elusive goal
Latest Video
Most Popular Recent Articles
Strachan Partners
Nigeria is the largest market in Africa and one of the fastest growing countries in the world. The country has a thriving and relatively easy business environment with numerous investment opportunities in various sectors.
Jones Day
On the heels of the European Union's General Data Protection law, which went into effect in May 2018
Holland & Knight
The Centers for Medicare & Medicaid Services (CMS) on Nov. 1, 2018, published the Calendar Year (CY) 2019 Final Rule for the Medicare Physician Fee Schedule (PFS).
NovoJuris Legal
The Personal Data Protection Bill, 2018 and the Data Protection Committee's Report (released on 27 July 2018) contains the framework and the policymakers' insight on protection of personal data in India.
BakerHostetler
Partners Carl Hittinger and Jeffry Duffy authored an article published by The Legal Intelligencer on July 27, 2018.
Foley Hoag LLP
The symbol at right is one of the three candidate food labeling symbols indicating the presence of "bioengineered foods" being proposed ...
Butler Snow LLP
Many state legislatures across the country have enacted statutory measures to limit the amount of compensatory and/or punitive damages recoverable ...
Frankfurt Kurnit Klein & Selz
Amid lawsuits and FDA action, JUUL Labs said it will stop selling its fruit-flavored e-cigarette pods in retail stores and will discontinue its social media promotions.
Blaney McMurtry LLP
On November 21, 2018, Bill 47, the Making Ontario Open for Business Act, passed third reading and received Royal Assent.
Goodmans LLP
On December 13, the Ontario government announced significant changes to the province's planned rollout of its retail cannabis regime.
Article Search Using Filters
Related Topics
Mondaq Advice Centre (MACs)
Popular Authors
Popular Contributors
Up-coming Events Search
Tools
Font Size:
Translation
Channels
Mondaq on Twitter